Mizuho Maintains Neutral on Amgen, Raises Price Target to $223
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Salim Syed maintains a Neutral rating on Amgen (NASDAQ:AMGN) and raises the price target from $214 to $223.
August 14, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mizuho maintains a Neutral rating on Amgen and raises the price target from $214 to $223, which may influence investor sentiment.
The news is directly about Amgen and its price target being raised by Mizuho. While the rating remains Neutral, the increased price target may influence investor sentiment and potentially the stock price, although the direction is not clear.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100